T1	HMM 895 965	percentages of CD3+, CD4+, CD56+, CD3+CD56+ cells, and CD4+/CD8+ ratio
T2	HMM 1152 1175	percentage of CD8 cells
T3	HMM 1232 1287	1-year and 18-month recurrence rates of the study group
